Table III.

Most Frequently Reported Adverse Events*

	Amlodipine Besylate/Benazepril HCl, No. (%)	Amlodipine Besylate Monotherapy, No. (%)
Subjects studied
Total	33	37
Total with adverse events	24 (72.7)	23 (62.2)
Total withdrawn for an adverse event	4(12.1)	1 (2.7)
Adverse event
Cough	7 (21.2)	4 (10.8)
Peripheral edema	0(0)	7 (18.9)
Nausea	6 (18.2)	0(0)
Headache	3 (9.1)	5 (13.5)
Joint swelling	1 (3.0)	5 (13.5)
Rhinitis	0(0)	3 (8.1)
*Adverse events reported by 3 or more subjects.